SharpGSIrvinWSTanEMGouldRGHolmanHR. Mixed connective tissue disease: An apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med1972;52:148–59.
BennettRMBongDMSpargoBH. Neuropsychiatric problems in mixed connective tissue disease. Am J Med1978;05:955–62.
4.
AshworthBATaitGBW. Trigeminal neuropathy in connective tissue disease. Neurology1971;21:609–14.
5.
LeckyBRFHughesRACMurrayNMF. Trigeminal sensory neuropathy: A study of 22 cases. Brain1987;110:1463–85.
6.
JacobsJMMacFarlaneRMCavanaghJB. Vascular leakage in the dorsal root ganglia of the rat, studied with horseradish peroxidase. J Neurol Sci1976;29:95–107.
7.
CurrieDMBradshawDC. Polyneuropathy in mixed connective tissue disease presenting as progressive systemic sclerosis (scleroderma): Case report and literature review. (Abstract)Arch Phys Med Rehab1979;60:549.
8.
WeissTDNelsonJSWoolseyRMZuckerJBaldassareAR. Transverse myelitis in mixed connective tissue disease. Arthritis Rheum1970;21:982–6.
9.
OetgenWJMutterMLLawlessOJDaviaJE. Cardiac abnormalities in mixed connective tissue disease. Chest1983;83:185–8.
10.
LashADWittmanA-LQuismorioFP. Myocarditis in mixed connective tissue disease: Clinical and pathologic study of three cases and review of the literature. Semin Arthritis Rheum1986;15:288–96.
11.
SchneiderHAYonkerRALongleySKatzPMathiasJPanushRS. Scleroderma esophagus: A nonspecific entity. Ann Intern Med1984;100:848–50.
12.
KiharaSMatsuzawaYKuboM. Autoimmune hyperchylomicronemia. N Engl J Med1989;320:1255–9.
13.
BrunzellJDMillerNEAlaupovicP. Familial chylomicronemia due to a circulating inhibitor of lipoprotein lipase activity. J Lipid Res1983;24:12–19.
14.
GlueckCJLevyRIGlueckHRGralnickHRGretenHFredricksonSD. Acquired type I hyperlipoproteinemia with systemic lupus erythematosus, dysglobulinemia and heparin resistance. Am J Med1969;47:318–24.
15.
PauciulloPDe SimoneBRubbaPManciniM. A case of association between type I hyperlipoproteinemia and systemic lupus erythematosus: Effects of steroid treatment. J Endocrinol Invest1986;9:517–20.
16.
LangerTLevyRI. Acute muscular syndrome associated with administration of clofibrate. N Engl J Med1968;279:856–8.
17.
SmalsAGHBeexLVAMKloppenborgPWC. Clofibrate induced muscle damage with myoglobinuria and cardiomyopathy. (Letter)N Engl J Med1977;296:942.
